AMELIA ANN FONG

Allopathic & Osteopathic Physicians|Ophthalmology HONOLULU, HI NPI 1104186311

General Payments — all program years on this page

$6,520.98

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 156
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,266.79 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,266.7918

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Sight Sciences, Inc. $567.634
Amgen Inc. $198.743
GLAUKOS CORPORATION $177.572
Bausch & Lomb Americas Inc. $167.022
ABBVIE INC. $93.374
Alcon Laboratories Inc $38.962
Oyster Point Pharma, Inc. $23.501

By program year

Program yearAmountRecords
2018 $922.2828
2019 $1,258.5428
2020 $411.6112
2021 $770.3530
2022 $945.1019
2023 $946.3121
2024 $1,266.7918

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103740863 ABBVIE INC. $23.97 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103740865 ABBVIE INC. $13.78 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103740867 ABBVIE INC. $32.75 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103740869 ABBVIE INC. $22.87 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110630350 Alcon Vision LLC $13.99 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110630352 Alcon Vision LLC $24.97 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111576020 Amgen Inc. $15.67 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111576022 Amgen Inc. $26.82 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117554985 Amgen Inc. $156.25 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140298882 Bausch & Lomb Americas Inc. $17.05 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140298884 Bausch & Lomb Americas Inc. $149.97 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147422757 Oyster Point Pharma, Inc. $23.50 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151921935 Sight Sciences, Inc. $140.63 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151921941 Sight Sciences, Inc. $141.05 01/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151921946 Sight Sciences, Inc. $141.55 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151921957 Sight Sciences, Inc. $144.40 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151977508 Glaukos Corporation $31.25 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151977510 Glaukos Corporation $146.32 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.